SKIN CANCER
BY:
Mr. M. Shivananda Reddy
• Skin cancer is the most commonly diagnosed
cancer.
• Skin cancers are either non-melanoma or
melanoma.
• A persistent skin lesion that does not heal is highly
suspicious for malignancy and should be
examined by a health care provider.
• Early detection and treatment can often lead to a
highly favourable prognosis.
• The visibility of the skin lesions increases the
likelihood of early detection and diagnosis
Risk Factors for Skin Cancer
• Damage in the ozone layer
• Fair-skinned and fair-haired people due to
insufficient skin pigmentation
• Prolonged exposure to sun light.
• Exposure to chemical pollutants(arsenic, nitrates,
coal, tar and pitch, oils and paraffins)
• History of x-ray therapy for acne or benign lesions
• Scars from severe burns
• Chronic skin irritations
• Immunosuppression
• Genetic factors
Types of skin cancers:
The most common types of skin cancer are:
• Basal Cell Carcinoma (BCC)
• Squamous cell (epidermoid) carcinoma (SCC).
• Malignant melanoma
Basal Cell Carcinoma (BCC)
• BCC is the most common type of skin cancer.
• It generally appears on sun-exposed areas of the body
and is more prevalent in regions where the population
is subjected to intense and extensive exposure to the
sun.
• The incidence is proportional to the age of the patient
and the total amount of sun exposure, and it is inversely
proportional to the amount of melanin in the skin.
• Basal cell carcinoma (BCC) is a locally
invasive malignancy arising from epidermal
basal cells. It is the most common type.
Clinical manifestations:
• BCC usually begins as a small, waxy nodule with rolled,
translucent, pearly borders; telangiectatic vessels may be
present.
• As it grows, it undergoes central ulceration and sometimes
crusting.
• The tumors appear most frequently on the face.
• BCC is characterized by invasion and erosion of adjoining
tissues.
• It rarely metastasizes, but recurrence is common.
BCC
Squamous Cell Carcinoma (SCC)
• Squamous cell carcinoma (SCC) is a malignant
neoplasm of keratinizing epidermal cells.
• It frequently occurs on sun-exposed skin or at the
base of skin lesion.
• SCC is less common than BCC.
• SCC can be highly aggressive, has the potential to
metastasize, and may lead to death if not treated early
and correctly.
Clinical manifestations:
• The lesions may be primary, arising on the skin and mucous
membranes, or they may develop from a precancerous
condition, such as scarred or ulcerated lesions.
• SCC appears as a rough, thickened, scaly tumor that may be
asymptomatic or may involve bleeding.
• The border of an SCC lesion may be wider, more infiltrated, and
more inflammatory than that of a BCC lesion.
• Exposed areas, especially of the upper extremities and of the
face, lower lip, ears, nose, and forehead, are common sites
Management of BCC & SCC
The treatment method depends on the tumor location; the cell
type, location, and depth; the cosmetic desires of the patient; the
history of previous treatment; whether the tumor is invasive, and
whether metastatic nodes are present.
The management of BCC and SCC includes
• Surgical excision
• Mohs’ micrographic surgery
• Electrosurgery
• Cryosurgery
• Radiation therapy
Surgical excision
• The primary goal is to remove the tumor entirely.
• When the tumor is large, reconstructive surgery
with use of a skin flap or skin grafting may be
required.
• A pressure dressing applied over the wound
provides support.
Mohs’ Micrographic Surgery.:
• The procedure removes the tumor layer by layer.
• The first layer excised includes all evident tumor and a
small margin of normal-appearing tissue.
• The specimen is frozen and analyzed by section to
determine if all the tumor has been removed.
• If not, additional layers of tissue are shaved and examined
until all tissue margins are tumor free.
• In this manner, only the tumor and a safe, normal-tissue
margin are removed.
Electro surgery
• Electro surgery is the destruction or removal of
tissue by electrical energy.
• The current is converted to heat, which then passes
to the tissue from an electrode.
Cryosurgery
• Cryosurgery destroys the tumor by deep
freezing the tissue.
• A thermocouple needle apparatus is inserted
into the skin, and liquid nitrogen is directed to
the center of the tumor until the tumor base is
−40°C to −60°C.
Radiation Therapy
• Expose the tumor surface to ionizing and
non-ionizing radiation to kill the cancerous
cells
Malignant Melanoma
• A malignant melanoma is a cancerous neoplasm
in which abnormal melanocytes are present in
the epidermis and the dermis (and sometimes the
subcutaneous cells).
• Most lethal of all the skin cancers
• Most melanomas arise from cutaneous epidermal
melanocytes
RISK FACTORS:
• The cause of malignant melanoma is unknown
• Ultraviolet rays are strongly suspected, based on
indirect evidence such as the increased incidence
of melanoma in countries near the equator
• Family history
Clinical Manifestations
• Superficial spreading melanoma occurs anywhere on
the body.
• It usually affects middle-aged people and occurs
most frequently on the trunk and lower extremities.
• The lesion tends to be circular, with irregular outer
portions.
• The margins of the lesion may be flat or elevated and
palpable.
• The malignant melanoma may appear in a
combination of colors, with hues of tan,
brown, and black mixed with gray, blue-
black, or white.
• Sometimes a dullpink rose color can be seen
in a small area within the lesion.
Management
• Surgical excision is the treatment of choice for
small, superficial lesions.
• Deeper lesions require wide local excision,
after which skin grafting may be needed.
• Regional lymph node dissection is commonly
performed to rule out metastasis.
• Immunotherapy:
• Monoclonal antibodies directed at melanoma antigens.
• Autologous immunization against specific tumor cells.
• Chemotherapy may be used for metastatic melanoma
Nursing diagnoses
• Acute pain related to surgical excision and grafting
• Anxiety and depression related to possible life-
threatening consequences of melanoma and
disfigurement
• Deficient knowledge about early signs of
melanoma
• Risk for infection related to break in the skin
barrier
Other Malignancies of the Skin
• Kaposi’s sarcoma
• Basal and Squamous cell carcinomas in the
immunocompromised population
KAPOSI’S SARCOMA
• Kaposi’s sarcoma (KS) has received renewed
attention since its association with HIV infection
and AIDS.
• Most patients have nodules or plaques on the
lower extremities that rarely metastasize beyond
the lower extremities.
• This KS is chronic, relatively benign, and rarely
fatal.
Basal and Squamous cell carcinomas
in immunocompromised
• The incidence of basal cell carcinoma and
squamous cell carcinoma is increased in all
immuno-compromised individuals, including those
infected with HIV.
• Clinically, the tumors have the same appearance as
in non–HIV-infected people; however, in HIV
patients, the tumors may grow more rapidly and
recur more frequently.
Skin Cancer disease detailed review and information

Skin Cancer disease detailed review and information

  • 1.
    SKIN CANCER BY: Mr. M.Shivananda Reddy
  • 2.
    • Skin canceris the most commonly diagnosed cancer. • Skin cancers are either non-melanoma or melanoma. • A persistent skin lesion that does not heal is highly suspicious for malignancy and should be examined by a health care provider. • Early detection and treatment can often lead to a highly favourable prognosis. • The visibility of the skin lesions increases the likelihood of early detection and diagnosis
  • 3.
    Risk Factors forSkin Cancer • Damage in the ozone layer • Fair-skinned and fair-haired people due to insufficient skin pigmentation • Prolonged exposure to sun light. • Exposure to chemical pollutants(arsenic, nitrates, coal, tar and pitch, oils and paraffins) • History of x-ray therapy for acne or benign lesions • Scars from severe burns • Chronic skin irritations • Immunosuppression • Genetic factors
  • 4.
    Types of skincancers: The most common types of skin cancer are: • Basal Cell Carcinoma (BCC) • Squamous cell (epidermoid) carcinoma (SCC). • Malignant melanoma
  • 5.
    Basal Cell Carcinoma(BCC) • BCC is the most common type of skin cancer. • It generally appears on sun-exposed areas of the body and is more prevalent in regions where the population is subjected to intense and extensive exposure to the sun. • The incidence is proportional to the age of the patient and the total amount of sun exposure, and it is inversely proportional to the amount of melanin in the skin.
  • 6.
    • Basal cellcarcinoma (BCC) is a locally invasive malignancy arising from epidermal basal cells. It is the most common type.
  • 7.
    Clinical manifestations: • BCCusually begins as a small, waxy nodule with rolled, translucent, pearly borders; telangiectatic vessels may be present. • As it grows, it undergoes central ulceration and sometimes crusting. • The tumors appear most frequently on the face. • BCC is characterized by invasion and erosion of adjoining tissues. • It rarely metastasizes, but recurrence is common.
  • 8.
  • 9.
    Squamous Cell Carcinoma(SCC) • Squamous cell carcinoma (SCC) is a malignant neoplasm of keratinizing epidermal cells. • It frequently occurs on sun-exposed skin or at the base of skin lesion. • SCC is less common than BCC. • SCC can be highly aggressive, has the potential to metastasize, and may lead to death if not treated early and correctly.
  • 10.
    Clinical manifestations: • Thelesions may be primary, arising on the skin and mucous membranes, or they may develop from a precancerous condition, such as scarred or ulcerated lesions. • SCC appears as a rough, thickened, scaly tumor that may be asymptomatic or may involve bleeding. • The border of an SCC lesion may be wider, more infiltrated, and more inflammatory than that of a BCC lesion. • Exposed areas, especially of the upper extremities and of the face, lower lip, ears, nose, and forehead, are common sites
  • 12.
    Management of BCC& SCC The treatment method depends on the tumor location; the cell type, location, and depth; the cosmetic desires of the patient; the history of previous treatment; whether the tumor is invasive, and whether metastatic nodes are present. The management of BCC and SCC includes • Surgical excision • Mohs’ micrographic surgery • Electrosurgery • Cryosurgery • Radiation therapy
  • 13.
    Surgical excision • Theprimary goal is to remove the tumor entirely. • When the tumor is large, reconstructive surgery with use of a skin flap or skin grafting may be required. • A pressure dressing applied over the wound provides support.
  • 14.
    Mohs’ Micrographic Surgery.: •The procedure removes the tumor layer by layer. • The first layer excised includes all evident tumor and a small margin of normal-appearing tissue. • The specimen is frozen and analyzed by section to determine if all the tumor has been removed. • If not, additional layers of tissue are shaved and examined until all tissue margins are tumor free. • In this manner, only the tumor and a safe, normal-tissue margin are removed.
  • 15.
    Electro surgery • Electrosurgery is the destruction or removal of tissue by electrical energy. • The current is converted to heat, which then passes to the tissue from an electrode.
  • 16.
    Cryosurgery • Cryosurgery destroysthe tumor by deep freezing the tissue. • A thermocouple needle apparatus is inserted into the skin, and liquid nitrogen is directed to the center of the tumor until the tumor base is −40°C to −60°C.
  • 17.
    Radiation Therapy • Exposethe tumor surface to ionizing and non-ionizing radiation to kill the cancerous cells
  • 19.
    Malignant Melanoma • Amalignant melanoma is a cancerous neoplasm in which abnormal melanocytes are present in the epidermis and the dermis (and sometimes the subcutaneous cells). • Most lethal of all the skin cancers • Most melanomas arise from cutaneous epidermal melanocytes
  • 20.
    RISK FACTORS: • Thecause of malignant melanoma is unknown • Ultraviolet rays are strongly suspected, based on indirect evidence such as the increased incidence of melanoma in countries near the equator • Family history
  • 21.
    Clinical Manifestations • Superficialspreading melanoma occurs anywhere on the body. • It usually affects middle-aged people and occurs most frequently on the trunk and lower extremities. • The lesion tends to be circular, with irregular outer portions. • The margins of the lesion may be flat or elevated and palpable.
  • 22.
    • The malignantmelanoma may appear in a combination of colors, with hues of tan, brown, and black mixed with gray, blue- black, or white. • Sometimes a dullpink rose color can be seen in a small area within the lesion.
  • 24.
    Management • Surgical excisionis the treatment of choice for small, superficial lesions. • Deeper lesions require wide local excision, after which skin grafting may be needed. • Regional lymph node dissection is commonly performed to rule out metastasis.
  • 25.
    • Immunotherapy: • Monoclonalantibodies directed at melanoma antigens. • Autologous immunization against specific tumor cells. • Chemotherapy may be used for metastatic melanoma
  • 26.
    Nursing diagnoses • Acutepain related to surgical excision and grafting • Anxiety and depression related to possible life- threatening consequences of melanoma and disfigurement • Deficient knowledge about early signs of melanoma • Risk for infection related to break in the skin barrier
  • 27.
    Other Malignancies ofthe Skin • Kaposi’s sarcoma • Basal and Squamous cell carcinomas in the immunocompromised population
  • 28.
    KAPOSI’S SARCOMA • Kaposi’ssarcoma (KS) has received renewed attention since its association with HIV infection and AIDS. • Most patients have nodules or plaques on the lower extremities that rarely metastasize beyond the lower extremities. • This KS is chronic, relatively benign, and rarely fatal.
  • 29.
    Basal and Squamouscell carcinomas in immunocompromised • The incidence of basal cell carcinoma and squamous cell carcinoma is increased in all immuno-compromised individuals, including those infected with HIV. • Clinically, the tumors have the same appearance as in non–HIV-infected people; however, in HIV patients, the tumors may grow more rapidly and recur more frequently.